Log in

Teladoc Health Stock Forecast, Price & News

-3.58 (-1.80 %)
(As of 12/1/2020 12:00 AM ET)
Today's Range
Now: $195.19
50-Day Range
MA: $202.48
52-Week Range
Now: $195.19
Volume2.49 million shs
Average Volume3.27 million shs
Market Capitalization$28.29 billion
P/E RatioN/A
Dividend YieldN/A
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, expert medical services, behavioral health solutions, guidance and support, and platform and program services. The company's platform enables patients and providers to have an integrated smart user experience through mobile, Web, and phone based accessed points. 0It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. Teladoc Health, Inc. offers its products and services under the Teladoc, Advance Medical, Best Doctors, BetterHelp, and HealthiestYou brands. Teladoc Health, Inc. has alliance with NTT DATA Services to build nucleus for healthcare. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was founded in 2002 and is headquartered in Purchase, New York.
Teladoc Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.66 out of 5 stars

Industry, Sector and Symbol

Industry Offices & clinics of medical doctors



Sales & Book Value

Annual Sales$553.31 million
Book Value$14.01 per share


Net Income$-98,860,000.00


Market Cap$28.29 billion
Next Earnings Date2/24/2021 (Estimated)
-3.58 (-1.80 %)
(As of 12/1/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TDOC News and Ratings via Email

Sign-up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Teladoc Health (NYSE:TDOC) Frequently Asked Questions

How has Teladoc Health's stock been impacted by COVID-19?

Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TDOC shares have increased by 42.1% and is now trading at $195.19.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Teladoc Health?

28 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 10 hold ratings and 18 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Teladoc Health
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Teladoc Health?

Wall Street analysts have given Teladoc Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Teladoc Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Teladoc Health's next earnings date?

Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for Teladoc Health

How were Teladoc Health's earnings last quarter?

Teladoc Health, Inc. (NYSE:TDOC) issued its quarterly earnings data on Wednesday, October, 28th. The health services provider reported ($0.43) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.33) by $0.10. The health services provider had revenue of $288.81 million for the quarter, compared to the consensus estimate of $281.54 million. Teladoc Health had a negative net margin of 13.22% and a negative return on equity of 9.54%.
View Teladoc Health's earnings history

What guidance has Teladoc Health issued on next quarter's earnings?

Teladoc Health issued an update on its fourth quarter 2020 After-Hours earnings guidance on Tuesday, November, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $369-379 million, compared to the consensus revenue estimate of $347.16 million.

What price target have analysts set for TDOC?

28 brokerages have issued 1 year price targets for Teladoc Health's stock. Their forecasts range from $80.00 to $305.00. On average, they anticipate Teladoc Health's stock price to reach $226.69 in the next twelve months. This suggests a possible upside of 16.1% from the stock's current price.
View analysts' price targets for Teladoc Health

Who are some of Teladoc Health's key competitors?

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Square (SQ), Shopify (SHOP), DocuSign (DOCU), salesforce.com (CRM), PayPal (PYPL) and Zoom Video Communications (ZM).

Who are Teladoc Health's key executives?

Teladoc Health's management team includes the following people:
  • Mr. Jason Nathanial Gorevic, CEO & Director (Age 48, Pay $1.2M)
  • Ms. Mala Murthy, Chief Financial Officer (Age 56, Pay $647.34k)
  • Mr. David William Sides, Chief Operating Officer (Age 49, Pay $927.41k)
  • Mr. Adam Christian Vandervoort, Chief Legal Officer & Sec. (Age 45, Pay $541k)
  • Ms. Stephany Verstraete, Chief Marketing Officer & Engagement Officer (Age 51, Pay $503.37k)
  • Mr. Gabriel Raymond Cappucci CPA, CPA, Sr. VP of Fin. (Age 57, Pay $425.5k)
  • Dr. George Byron Brooks, Co-Founder
  • Mr. Patrick Thomas Feeley C.F.A., CPA, CPA, CFA, VP of Investor Relations
  • Ms. Courtney Kraemer McLeod, Director of Communication
  • Mr. Andrew Turitz, Sr. VP of Corp. Devel. (Age 47)

When did Teladoc Health IPO?

(TDOC) raised $112 million in an initial public offering (IPO) on Wednesday, July 1st 2015. The company issued 7,000,000 shares at $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

What is Teladoc Health's stock symbol?

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by many different retail and institutional investors. Top institutional investors include Jennison Associates LLC (7.18%), ARK Investment Management LLC (2.43%), State Street Corp (1.81%), Arrowstreet Capital Limited Partnership (1.33%), Nikko Asset Management Americas Inc. (1.25%) and First Trust Advisors LP (1.22%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, David L Shedlarz, David William Sides, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Mark Hirschhorn, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen, Stephany Verstraete and William H Frist.
View institutional ownership trends for Teladoc Health

Which institutional investors are selling Teladoc Health stock?

TDOC stock was sold by a variety of institutional investors in the last quarter, including Federated Hermes Inc., Charles Schwab Investment Management Inc., Peregrine Capital Management LLC, Riverbridge Partners LLC, Cubist Systematic Strategies LLC, Westwood Management Corp IL, Spence Asset Management, and Assenagon Asset Management S.A.. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, David L Shedlarz, David William Sides, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Stephany Verstraete, and William H Frist.
View insider buying and selling activity for Teladoc Health

Which institutional investors are buying Teladoc Health stock?

TDOC stock was purchased by a variety of institutional investors in the last quarter, including Jennison Associates LLC, ARK Investment Management LLC, Nikko Asset Management Americas Inc., Thrivent Financial for Lutherans, Nuveen Asset Management LLC, Blair William & Co. IL, Natixis, and AQR Capital Management LLC.
View insider buying and selling activity for Teladoc Health

How do I buy shares of Teladoc Health?

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Teladoc Health's stock price today?

One share of TDOC stock can currently be purchased for approximately $195.19.

How big of a company is Teladoc Health?

Teladoc Health has a market capitalization of $28.29 billion and generates $553.31 million in revenue each year. The health services provider earns $-98,860,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis. Teladoc Health employs 3,276 workers across the globe.

What is Teladoc Health's official website?

The official website for Teladoc Health is www.teladochealth.com.

How can I contact Teladoc Health?

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]

This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.